Business Description
Cosciens Biopharma Inc
NAICS : 325412
SIC : 3741
Description
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 16.48 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.33 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 0.62 | |||||
| Beneish M-Score | -1.97 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -13.8 | |||||
| 3-Year Book Growth Rate | 4.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 46.77 | |||||
| 9-Day RSI | 45.05 | |||||
| 14-Day RSI | 42.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.36 | |||||
| Quick Ratio | 3.05 | |||||
| Cash Ratio | 2.81 | |||||
| Days Inventory | 269.17 | |||||
| Days Sales Outstanding | 42.56 | |||||
| Days Payable | 266.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.3 | |||||
| Shareholder Yield % | 1.43 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 35.52 | |||||
| Operating Margin % | -114.54 | |||||
| Net Margin % | -67.87 | |||||
| FCF Margin % | -80.63 | |||||
| ROE % | -23.49 | |||||
| ROA % | -17.9 | |||||
| ROIC % | -39.52 | |||||
| 3-Year ROIIC % | 532.13 | |||||
| ROC (Joel Greenblatt) % | -45.16 | |||||
| ROCE % | -25.1 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 7.04 | |||||
| PS Ratio | 0.97 | |||||
| PB Ratio | 0.44 | |||||
| Price-to-Tangible-Book | 0.49 | |||||
| EV-to-EBIT | 2.31 | |||||
| EV-to-EBITDA | 2.97 | |||||
| EV-to-Revenue | -1.98 | |||||
| EV-to-FCF | 2.38 | |||||
| Price-to-Projected-FCF | 0.4 | |||||
| Price-to-Median-PS-Value | 0.33 | |||||
| Price-to-Net-Current-Asset-Value | 1.19 | |||||
| Price-to-Net-Cash | 2.8 | |||||
| Earnings Yield (Greenblatt) % | 43.21 | |||||
| FCF Yield % | -54.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cosciens Biopharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 7.14 | ||
| EPS (TTM) (€) | -2.364 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 42.63 | ||
| 14-Day ATR (€) | 0.096522 | ||
| 20-Day SMA (€) | 3.338 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 3.18 - 6.72 | ||
| Shares Outstanding (Mil) | 3.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cosciens Biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cosciens Biopharma Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cosciens Biopharma Inc Frequently Asked Questions
What is Cosciens Biopharma Inc(STU:ET8)'s stock price today?
The current price of STU:ET8 is €3.28. The 52 week high of STU:ET8 is €6.72 and 52 week low is €3.18.
When is next earnings date of Cosciens Biopharma Inc(STU:ET8)?
The next earnings date of Cosciens Biopharma Inc(STU:ET8) is .
Does Cosciens Biopharma Inc(STU:ET8) pay dividends? If so, how much?
Cosciens Biopharma Inc(STU:ET8) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers